Latest articles
- H.R. 6000: 21st Century Cures 2.0
- FDA authorizes marketing of virtual reality device for back pain
- FDA publishes draft guidance on premarket submissions for software
- FDA, with British and Canadian regulators, identifies guiding principles for AI/ML
- Employer health plans increased telemedicine coverage during 2021
Trending
- FDA, with British and Canadian regulators, identifies guiding principles for AI/ML
- Employer health plans increased telemedicine coverage during 2021
- FDA publishes draft guidance on premarket submissions for software
- FDA authorizes marketing of virtual reality device for back pain
- H.R. 6000: 21st Century Cures 2.0